PIM
TECH icon

Plato Investment Management’s Bio-Techne TECH Stock Holding History

Plato Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,739
Closed -$243K – 537
2025
Q2 		$243K Hold
4,739
– – 0.02% 395
2025
Q1 		$281K Buy
+4,739
New +$321K 0.02% 378

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Plato Investment Management's TECH Position: Q3 2025 in Review

Plato Investment Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 4,739 shares — an estimated $243K sold.

Plato Investment Management first reported a position in TECH in Q1 2025 and held it in 2 quarters. The position peaked at $281K in Q1 2025. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Plato Investment Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Plato Investment Management sold 4,739 Bio-Techne shares in Q3 2025, an estimated $243K.
  • Plato Investment Management first reported a position in Bio-Techne in Q1 2025 and held it in 2 quarters.
  • Plato Investment Management's Bio-Techne position peaked at $281K in Q1 2025.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Plato Investment Management's 13F filing for Q3 2025, filed 5 Nov 2025.